Brief: Clearbridge Health Enters Term Sheet For Elpis Biopharmaceuticals Acquisition
28/04/2025 11:24
April 28 (Reuters) - Clearbridge Health Ltd CLEA.SI: ENTERS TERM SHEET FOR ELPIS BIOPHARMACEUTICALS ACQUISITION ACQUISITION CONSIDERATION SET AT US$330 MILLION Source text: ID:nSN8wjbpd Further company coverage: CLEA.SI ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Clearbridge Health
See all newsBrief: Clearbridge Health Says Cessation Of Wu Yu Liang As Independent Chairman
Brief: Clearbridge Health Says Cessation Of Wu Yu Liang As Non-Executive And Independent Chairman
Brief: Clearbridge Health's Unit Sells 100% Of Clearbridge Medical Hong Kong
Singapore's Clearbridge Health half-year revenue falls on discontinued Dental Group operations
Brief: Clearbridge Health Appoints Wu Yu Liang As Non-Executive And Independent Chairman